avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cebpa
|
ENSMUSG00000034957.9 | CCAAT/enhancer binding protein (C/EBP), alpha |
Cebpg
|
ENSMUSG00000056216.8 | CCAAT/enhancer binding protein (C/EBP), gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cebpa | mm10_v2_chr7_+_35119285_35119301 | 0.58 | 2.1e-04 | Click! |
Cebpg | mm10_v2_chr7_-_35056467_35056556 | 0.06 | 7.2e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.4 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
1.8 | 10.6 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.3 | 1.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 3.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.7 | 0.7 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
0.6 | 1.8 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.5 | 2.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.5 | 15.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.4 | 0.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 5.1 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 1.8 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.3 | 15.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 1.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 2.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.2 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.2 | 0.7 | GO:0006507 | GPI anchor release(GO:0006507) response to iron(II) ion(GO:0010040) |
0.2 | 0.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.2 | 1.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.9 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.2 | 4.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 5.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 1.4 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.2 | 0.6 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.2 | 0.3 | GO:0045818 | negative regulation of glycogen catabolic process(GO:0045818) |
0.2 | 0.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 1.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 1.1 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 6.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 3.5 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 2.0 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:1990868 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.1 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 2.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.7 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.4 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.0 | 1.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.2 | GO:2001184 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 11.1 | GO:0008202 | steroid metabolic process(GO:0008202) |
0.0 | 2.2 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 1.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 2.0 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0030913 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.0 | 1.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.0 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.8 | 10.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 2.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 12.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 1.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.3 | 15.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 13.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 1.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 3.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 2.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 3.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 39.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.6 | 15.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.8 | 3.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.7 | 2.0 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.4 | 10.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 2.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 1.1 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.3 | 11.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 5.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.2 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.3 | 6.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 1.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 1.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 2.7 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 13.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 1.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 5.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 5.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 3.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 2.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 3.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 3.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 2.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 1.2 | GO:0005262 | calcium channel activity(GO:0005262) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 6.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 15.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 10.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 4.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 6.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 2.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 15.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 6.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 2.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 1.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 3.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 12.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |